Continuous Positive Airway Pressure Treatment, Glycemia, and Diabetes Risk in Obstructive Sleep Apnea and Comorbid Cardiovascular Disease

Study (n=274) found, among patients with established CVD and obstructive sleep apnoea, no evidence that continuous positive airway pressure therapy affects glycaemic control in those with diabetes or prediabetes or diabetes risk over standard-of-care treatment.

Source:

Diabetes Care